GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » PB Ratio

Biotage AB (Biotage AB) PB Ratio : 3.13 (As of Apr. 26, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), Biotage AB's share price is $14.63. Biotage AB's Book Value per Share for the quarter that ended in Mar. 2024 was $4.67. Hence, Biotage AB's PB Ratio of today is 3.13.

The historical rank and industry rank for Biotage AB's PB Ratio or its related term are showing as below:

BITGF' s PB Ratio Range Over the Past 10 Years
Min: 1.16   Med: 6.78   Max: 16.88
Current: 3.39

During the past 13 years, Biotage AB's highest PB Ratio was 16.88. The lowest was 1.16. And the median was 6.78.

BITGF's PB Ratio is ranked worse than
69.81% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs BITGF: 3.39

During the past 12 months, Biotage AB's average Book Value Per Share Growth Rate was 90.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 44.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 30.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 18.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Biotage AB was 44.40% per year. The lowest was -17.70% per year. And the median was 5.60% per year.

Back to Basics: PB Ratio


Biotage AB PB Ratio Historical Data

The historical data trend for Biotage AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB PB Ratio Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.60 8.81 12.88 7.11 2.69

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.91 2.76 2.32 2.69 3.61

Competitive Comparison of Biotage AB's PB Ratio

For the Medical Instruments & Supplies subindustry, Biotage AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biotage AB's PB Ratio falls into.



Biotage AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Biotage AB's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=14.63/4.669
=3.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Biotage AB  (OTCPK:BITGF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Biotage AB PB Ratio Related Terms

Thank you for viewing the detailed overview of Biotage AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines